Bioburden Testing Market by Product (Consumables, Instrument (PCR, Microscope)), Test (Anerobic, Mold/Fungi, Aerobic, Spore), Application (Raw Material, Medical Devices, Sterility Testing), End User (Pharma, Biotechnology, CMO) - Global Forecast to 2023

バイオバーデン試験の世界市場予測(~2023年)

◆タイトル:Bioburden Testing Market by Product (Consumables, Instrument (PCR, Microscope)), Test (Anerobic, Mold/Fungi, Aerobic, Spore), Application (Raw Material, Medical Devices, Sterility Testing), End User (Pharma, Biotechnology, CMO) - Global Forecast to 2023
◆商品コード:BT-3394
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年12月6日
◆ページ数:130
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥604,550見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥711,550見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥872,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、バイオバーデン試験の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別(消耗品、装置)分析、試験別分析、用途別分析、需要先別分析、バイオバーデン試験の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Growth in the medical devices, pharmaceutical, and biotechnology industries to drive the growth of the bioburden testing market”The bioburden testing market is projected to reach USD 1,103 million by 2023 from USD 614 million in 2018, at a CAGR of 12.4% during the forecast period. A number of factors, such as the growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination are expected to drive the growth of this market during the forecast period. However, the high cost of enumeration instruments is expected to restrain market growth in the coming years.

“Consumables segment to witness the highest CAGR in the bioburden testing products market during the forecast period”

Based on product, the bioburden testing market is segmented into consumables and instruments.
The consumables market is further segmented into culture media, reagents, and kits, and other consumables, while the market for instruments is further categorized as automated microbial identification systems, PCR instruments, microscopes, and other instruments. In 2018, the consumables segment is expected to register the highest CAGR during the forecast period, majorly due to the recurrent purchase of kits and reagents, as opposed to instruments which are considered as a one-time investment.

“Aerobic count segment to account for the largest share of the bioburden testing market, by test type”

Based on test type, the bioburden testing market is segmented into aerobic count, anaerobic count, fungi/mold count, and spore count. In 2018, the aerobic count segment is expected to account for the largest share of the bioburden testing market, by test type. This segment is also expected to witness the highest CAGR during the forecast period. Growth in this segment can be attributed to the necessity of performing aerobic count tests in order to ensure the safety of pharmaceutical and biotechnology products.

“North America to dominate the bioburden testing market during the forecast period”

North America is expected to account for the largest share of the bioburden testing market in 2018. The large size of the North American biotechnology industry will aid in the growth of the bioburden testing market in this region. However, the Asian market is expected to grow at the highest CAGR during the forecast period. Strong investments and rapid growth in the pharmaceutical and biotechnology industries will drive the growth of the bioburden testing market in this region.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1: 37%, Tier 2: 22%, and Tier 3: 41%
• By Designation: C-level: 25%, D-level: 20%, and Others: 55%
• By Region: North America: 40%, Europe: 27%, Asia: 20%, and the RoW: 13%

List of Companies Profiled in the Report
• Charles River (US)
• Merck KGaA (Germany)
• SGS SA (Switzerland)
• WuXi AppTec (China)
• Becton, Dickinson and Company (US)
• NAMSA (US)
• Nelson Laboratories, LLC (US)
• Thermo Fisher Scientific, Inc. (US)
• biomérieux SA (France)
• Pacific BioLabs (US)

Research Coverage
This report provides a picture of the global bioburden testing market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, test type, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report
The report will help market leaders/new entrants by providing them the closest approximations of the revenue numbers for the overall bioburden testing market and its subsegments. Also, this report will help stakeholders to better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.2.1 MARKETS COVERED 15
1.2.2 YEARS CONSIDERED FOR THE STUDY 15
1.3 CURRENCY 16
1.4 LIMITATIONS 16
1.5 MARKET STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.1.1 SECONDARY DATA 18
2.1.1.1 Key data from secondary sources 18
2.1.2 PRIMARY DATA 18
2.1.2.1 Key data from primary sources 19
2.2 MARKET SIZE ESTIMATION 19
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 21
2.4 ASSUMPTIONS FOR THE STUDY 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 28
4.1 BIOBURDEN TESTING MARKET: MARKET OVERVIEW 28
4.2 BIOBURDEN TESTING MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION) 29
4.3 BIOBURDEN TESTING MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION) 29
4.4 BIOBURDEN TESTING MARKET, BY END USER 30
4.5 GEOGRAPHIC ANALYSIS: BIOBURDEN TESTING MARKET 31
4.6 GEOGRAPHICAL SNAPSHOT OF THE BIOBURDEN TESTING MARKET 32
5 MARKET OVERVIEW 33
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 34
5.2.1.1 Growth in the medical devices, pharmaceutical, and biotechnology industries 34
5.2.1.2 Rising safety concerns related to food and beverage products 34
5.2.1.3 Increasing number of product recalls due to microbial contamination 34
5.2.2 RESTRAINTS 35
5.2.2.1 High cost of enumeration instruments 35
5.2.3 OPPORTUNITIES 35
5.2.3.1 Growth opportunities in emerging economies 35
5.2.4 CHALLENGES 35
5.2.4.1 Shortage of skilled professionals 35
6 BIOBURDEN TESTING MARKET, BY PRODUCT 36
6.1 INTRODUCTION 37
6.2 CONSUMABLES 38
6.2.1 CULTURE MEDIA, REAGENTS, AND KITS 39
6.2.1.1 Culture media, reagents, and kits to witness the highest growth in the bioburden testing consumables market 39
6.2.2 OTHER CONSUMABLES 39
6.3 INSTRUMENTS 40
6.3.1 AUTOMATED MICROBIAL IDENTIFICATION SYSTEMS 41
6.3.1.1 Automated microbial identification systems to witness the highest growth, primarily due to the ease of use of these systems and their ability to produce cost-effective results 41
6.3.2 PCR INSTRUMENTS 42
6.3.2.1 PCR instruments find applications in molecular biology, recombinant DNA technology, and genotypic identification 42
6.3.3 MICROSCOPES 43
6.3.3.1 Low cost of microscopes has resulted in their increased adoption, especially in developing countries 43
6.3.4 OTHER INSTRUMENTS 44
7 BIOBURDEN TESTING MARKET, BY TEST TYPE 45
7.1 INTRODUCTION 46
7.2 AEROBIC COUNT TESTING 47
7.2.1 THESE TESTS CHECK FOR THE MOST FREQUENTLY FOUND CONTAMINANTS THAT CAN AFFECT FINISHED PRODUCTS 47
7.3 ANAEROBIC COUNT TESTING 48
7.3.1 NEED TO TEST FOR ANAEROBIC MICROORGANISMS IN RAW MATERIALS AND CANNED FOOD WILL DRIVE MARKET GROWTH 48
7.4 FUNGI/MOLD COUNT TESTING 49
7.4.1 USED TO DETECT BIOBURDEN AFFECTING PAINT, GLASS, ELECTRICAL EQUIPMENT 49
7.5 SPORE COUNT TESTING 49
7.5.1 RESISTANCE TO STERILIZERS MAKES IT IMPORTANT TO CHECK FOR SPORES 49

8 BIOBURDEN TESTING MARKET, BY APPLICATION 51
8.1 INTRODUCTION 52
8.2 RAW MATERIAL TESTING 53
8.2.1 RAW MATERIALS CAN BE MAJOR CONTRIBUTORS TO THE BIOBURDEN COUNT OF THE FINISHED PRODUCT 53
8.3 MEDICAL DEVICE TESTING 54
8.3.1 FAVORABLE REGULATIONS FOR MEDICAL DEVICE MANUFACTURING HAVE SUSTAINED THE DEMAND FOR BIOBURDEN TESTING 54
8.4 IN-PROCESS MATERIAL TESTING 55
8.4.1 RECOMMENDATIONS FOR IN-CONTROL MATERIAL TESTING FOR BIOBURDEN CONTRIBUTE TO THE GROWTH OF THE MARKET 55
8.5 STERILIZATION VALIDATION TESTING 56
8.5.1 STERILITY VALIDATION IS MANDATED FOR BIOLOGICS 56
8.6 EQUIPMENT CLEANING VALIDATION 57
8.6.1 TO AVOID CONTAMINATION FROM THE FINAL PRODUCT, MANUFACTURING EQUIPMENT MUST BE CLEANED ENOUGH TO USE 57
9 BIOBURDEN TESTING MARKET, BY END USER 58
9.1 INTRODUCTION 59
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 60
9.2.1 GROWING NUMBER OF DRUG RECALLS DUE TO MICROBIAL CONTAMINATION—KEY DRIVER FOR THIS END-USER SEGMENT 60
9.3 MEDICAL DEVICE MANUFACTURERS 61
9.3.1 GROWTH IN THE MEDICAL DEVICE INDUSTRY IS DRIVING THE DEMAND FOR BIOBURDEN TESTING AMONG MEDICAL DEVICE MANUFACTURERS 61
9.4 CONTRACT MANUFACTURING ORGANIZATIONS 62
9.4.1 CONTRACT MANUFACTURING ORGANIZATIONS TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 62
9.5 MANUFACTURERS OF FOOD & BEVERAGE AND AGRICULTURAL PRODUCTS 63
9.5.1 RISING CONCERNS RELATED TO THE SAFETY OF FOOD & BEVERAGE PRODUCTS IS DRIVING THE GROWTH OF THE BIOBURDEN TESTING MARKET 63
9.6 MICROBIAL TESTING LABORATORIES 64
9.6.1 MICROBIAL TESTING LABORATORIES ARE EQUIPPED WITH ADVANCED AUTOMATED TOOLS TO CARRY OUT COMPLEX, SPECIALIZED, AND OBSCURE TESTS 64
10 BIOBURDEN TESTING MARKET, BY REGION 65
10.1 INTRODUCTION 66
10.2 NORTH AMERICA 67
10.2.1 US 72
10.2.1.1 Increasing food imports into the US will contribute to market growth 72
10.2.2 CANADA 75
10.2.2.1 R&D activity is increasing in Canada, supported by rising expenditure 75

10.3 EUROPE 77
10.3.1 GERMANY 82
10.3.1.1 Strong infrastructural base and increasing public-private collaboration will favor market growth 82
10.3.2 UK 84
10.3.2.1 One-third of the UK’s biotech companies are engaged in drug R&D 84
10.3.3 FRANCE 87
10.3.3.1 High consumption of pharma products has drawn attention to generics, to cut costs 87
10.3.4 REST OF EUROPE 89
10.4 ASIA 92
10.4.1 GROWTH OF THE PHARMA INDUSTRY IN CHINA AND INDIA WILL DRIVE BIOBURDEN TESTING ACTIVITY 92
10.5 REST OF THE WORLD 95
11 COMPETITIVE LANDSCAPE 98
11.1 OVERVIEW 98
11.2 MARKET RANKING ANALYSIS 99
11.3 COMPETITIVE SITUATION AND TRENDS 100
11.3.1 EXPANSIONS 100
11.3.2 ACQUISITIONS 100
11.3.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 101
11.3.4 PRODUCT LAUNCHES 102
12 COMPANY PROFILES 103
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 CHARLES RIVER 103
12.2 MERCK KGAA 105
12.3 SGS SA 108
12.4 WUXI APPTEC 111
12.5 BD 113
12.6 NORTH AMERICAN SCIENCE ASSOCIATES INC. (NAMSA) 115
12.7 NELSON LABORATORIES, LLC 116
12.8 THERMO FISHER SCIENTIFIC 117
12.9 BIOMÉRIEUX SA 119
12.10 PACIFIC BIOLABS 121

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13 APPENDIX 122
13.1 INSIGHTS FROM INDUSTRY EXPERTS 122
13.2 DISCUSSION GUIDE 123
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 126
13.4 AVAILABLE CUSTOMIZATIONS 128
13.5 RELATED REPORTS 128
13.6 AUTHOR DETAILS 129

LIST OF TABLES

TABLE 1 PRODUCT RECALLS DURING 2017–2018 34
TABLE 2 BIOBURDEN TESTING MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 37
TABLE 3 BIOBURDEN TESTING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 38
TABLE 4 BIOBURDEN TESTING CONSUMABLES MARKET, BY REGION,
2016–2023 (USD MILLION) 38
TABLE 5 CULTURE MEDIA, REAGENTS, AND KITS MARKET, BY REGION,
2016–2023 (USD MILLION) 39
TABLE 6 OTHER CONSUMABLES MARKET, BY REGION, 2016–2023 (USD MILLION) 40
TABLE 7 BIOBURDEN TESTING INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 40
TABLE 8 BIOBURDEN TESTING INSTRUMENTS MARKET, BY REGION,
2016–2023 (USD MILLION) 41
TABLE 9 AUTOMATED MICROBIAL IDENTIFICATION SYSTEMS MARKET,
BY REGION, 2016–2023 (USD MILLION) 42
TABLE 10 PCR INSTRUMENTS MARKET, BY REGION, 2016–2023 (USD MILLION) 42
TABLE 11 MICROSCOPES MARKET, BY REGION, 2016–2023 (USD MILLION) 43
TABLE 12 OTHER INSTRUMENTS MARKET, BY REGION, 2016–2023 (USD MILLION) 44
TABLE 13 BIOBURDEN TESTING MARKET, BY TEST TYPE, 2016–2023 (USD MILLION) 46
TABLE 14 AEROBIC COUNT TESTING MARKET, BY REGION, 2016–2023 (USD MILLION) 47
TABLE 15 ANAEROBIC COUNT TESTING MARKET, BY REGION, 2016–2023 (USD MILLION) 48
TABLE 16 BIOBURDEN TESTING MARKET FOR FUNGI/MOLD COUNT TESTING, BY REGION, 2016–2023 (USD MILLION) 49
TABLE 17 BIOBURDEN TESTING MARKET FOR SPORE COUNT TESTING, BY REGION,
2016–2023 (USD MILLION) 50
TABLE 18 BIOBURDEN TESTING MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 52
TABLE 19 BIOBURDEN TESTING MARKET FOR RAW MATERIAL TESTING, BY REGION,
2016–2023 (USD MILLION) 53
TABLE 20 BIOBURDEN TESTING MARKET FOR MEDICAL DEVICE TESTING, BY REGION,
2016–2023 (USD MILLION) 54
TABLE 21 BIOBURDEN TESTING MARKET FOR IN-PROCESS MATERIAL TESTING,
BY REGION, 2016–2023 (USD MILLION) 55
TABLE 22 BIOBURDEN TESTING MARKET FOR STERILIZATION VALIDATION TESTING,
BY REGION, 2016–2023 (USD MILLION) 56
TABLE 23 BIOBURDEN TESTING MARKET FOR EQUIPMENT CLEANING VALIDATION,
BY REGION, 2016–2023 (USD MILLION) 57
TABLE 24 BIOBURDEN TESTING MARKET, BY END USER, 2016–2023 (USD MILLION) 59
TABLE 25 BIOBURDEN TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2023 (USD MILLION) 60
TABLE 26 BIOBURDEN TESTING MARKET FOR MEDICAL DEVICE MANUFACTURERS,
BY REGION, 2016–2023 (USD MILLION) 61
TABLE 27 BIOBURDEN TESTING MARKET FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2016–2023 (USD MILLION) 62
TABLE 28 BIOBURDEN TESTING MARKET FOR MANUFACTURERS OF FOOD & BEVERAGE
AND AGRICULTURAL PRODUCTS, BY REGION, 2016–2023 (USD MILLION) 63
TABLE 29 BIOBURDEN TESTING MARKET FOR MICROBIAL TESTING LABORATORIES,
BY REGION, 2016–2023 (USD MILLION) 64
TABLE 30 BIOBURDEN TESTING MARKET, BY REGION, 2016–2023 (USD MILLION) 66
TABLE 31 NORTH AMERICA: BIOBURDEN TESTING MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 69
TABLE 32 NORTH AMERICA: BIOBURDEN TESTING MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 69
TABLE 33 NORTH AMERICA: BIOBURDEN TESTING CONSUMABLES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 70
TABLE 34 NORTH AMERICA: BIOBURDEN TESTING INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 70
TABLE 35 NORTH AMERICA: BIOBURDEN TESTING MARKET, BY TEST TYPE,
2016–2023 (USD MILLION) 71
TABLE 36 NORTH AMERICA: BIOBURDEN TESTING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 71
TABLE 37 NORTH AMERICA: BIOBURDEN TESTING MARKET, BY END USER,
2016–2023 (USD MILLION) 72
TABLE 38 US: BIOBURDEN TESTING MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 73
TABLE 39 US: BIOBURDEN TESTING MARKET, BY TEST TYPE, 2016–2023 (USD MILLION) 73
TABLE 40 US: BIOBURDEN TESTING MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 74
TABLE 41 US: BIOBURDEN TESTING MARKET, BY END USER, 2016–2023 (USD MILLION) 74
TABLE 42 CANADA: BIOBURDEN TESTING MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 75
TABLE 43 CANADA: BIOBURDEN TESTING MARKET, BY TEST TYPE,
2016–2023 (USD MILLION) 76
TABLE 44 CANADA: BIOBURDEN TESTING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 76
TABLE 45 CANADA: BIOBURDEN TESTING MARKET, BY END USER,
2016–2023 (USD MILLION) 77
TABLE 46 EUROPE: BIOBURDEN TESTING MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 79
TABLE 47 EUROPE: BIOBURDEN TESTING MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 79
TABLE 48 EUROPE: BIOBURDEN TESTING CONSUMABLES MARKET,
BY TYPE, 2016–2023 (USD MILLION) 79
TABLE 49 EUROPE: BIOBURDEN TESTING INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 80
TABLE 50 EUROPE: BIOBURDEN TESTING MARKET, BY TEST TYPE,
2016–2023 (USD MILLION) 80
TABLE 51 EUROPE: BIOBURDEN TESTING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 81
TABLE 52 EUROPE: BIOBURDEN TESTING MARKET, BY END USER,
2016–2023 (USD MILLION) 81
TABLE 53 GERMANY: BIOBURDEN TESTING MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 82
TABLE 54 GERMANY: BIOBURDEN TESTING MARKET, BY TEST TYPE,
2016–2023 (USD MILLION) 83
TABLE 55 GERMANY: BIOBURDEN TESTING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 83
TABLE 56 GERMANY: BIOBURDEN TESTING MARKET, BY END USER,
2016–2023 (USD MILLION) 84
TABLE 57 UK: BIOBURDEN TESTING MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 85
TABLE 58 UK: BIOBURDEN TESTING MARKET, BY TEST TYPE, 2016–2023 (USD MILLION) 85
TABLE 59 UK: BIOBURDEN TESTING MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 86
TABLE 60 UK: BIOBURDEN TESTING MARKET, BY END USER, 2016–2023 (USD MILLION) 86
TABLE 61 FRANCE: BIOBURDEN TESTING MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 87
TABLE 62 FRANCE: BIOBURDEN TESTING MARKET, BY TEST TYPE,
2016–2023 (USD MILLION) 88
TABLE 63 FRANCE: BIOBURDEN TESTING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 88
TABLE 64 FRANCE: BIOBURDEN TESTING MARKET, BY END USER,
2016–2023 (USD MILLION) 89
TABLE 65 ROE: BIOBURDEN TESTING MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 90
TABLE 66 ROE: BIOBURDEN TESTING MARKET, BY TEST TYPE, 2016–2023 (USD MILLION) 90
TABLE 67 ROE: BIOBURDEN TESTING MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 91
TABLE 68 ROE: BIOBURDEN TESTING MARKET, BY END USER, 2016–2023 (USD MILLION) 91
TABLE 69 ASIA: BIOBURDEN TESTING MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 93
TABLE 70 ASIA: BIOBURDEN TESTING CONSUMABLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 93
TABLE 71 ASIA: BIOBURDEN TESTING INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 93
TABLE 72 ASIA: BIOBURDEN TESTING MARKET, BY TEST TYPE, 2016–2023 (USD MILLION) 94
TABLE 73 ASIA: BIOBURDEN TESTING MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 94
TABLE 74 ASIA: BIOBURDEN TESTING MARKET, BY END USER, 2016–2023 (USD MILLION) 95
TABLE 75 ROW: BIOBURDEN TESTING MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 96
TABLE 76 ROW: BIOBURDEN TESTING MARKET, BY TEST TYPE, 2016–2023 (USD MILLION) 96
TABLE 77 ROW: BIOBURDEN TESTING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 97
TABLE 78 ROW: BIOBURDEN TESTING MARKET, BY END USER, 2016–2023 (USD MILLION) 97


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 17
FIGURE 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 20
FIGURE 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 20
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 21
FIGURE 5 DATA TRIANGULATION METHODOLOGY 22
FIGURE 6 BIOBURDEN TESTING, BY PRODUCT, 2018 VS. 2023 (USD MILLION) 24
FIGURE 7 BIOBURDEN TESTING MARKET, BY TEST TYPE, 2018 VS. 2023 (USD MILLION) 25
FIGURE 8 BIOBURDEN TESTING MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION) 25
FIGURE 9 BIOBURDEN TESTING MARKET, BY END USER, 2018–2023 (USD MILLION) 26
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE BIOBURDEN TESTING MARKET 27
FIGURE 11 RISING SAFETY CONCERNS RELATED TO FOOD AND BEVERAGE PRODUCTS
—A KEY FACTOR DRIVING MARKET GROWTH 28
FIGURE 12 CONSUMABLES TO DOMINATE THE BIOBURDEN TESTING PRODUCTS MARKET BETWEEN 2018 & 2023 29
FIGURE 13 RAW MATERIAL TESTING SEGMENT TO DOMINATE THE BIOBURDEN TESTING MARKET DURING THE FORECAST PERIOD 29
FIGURE 14 CONTRACT MANUFACTURING ORGANIZATIONS TO REGISTER THE HIGHEST CAGR DURING 2018–2023 30
FIGURE 15 AEROBIC COUNT SEGMENT TO ACCOUNT FOR THE LARGEST MARKET
SHARE IN 2018 31
FIGURE 16 ASIA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
(2018–2023) 32
FIGURE 17 BIOBURDEN TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 33
FIGURE 18 CONSUMABLES SEGMENT TO DOMINATE THE BIOBURDEN TESTING PRODUCTS MARKET DURING THE FORECAST PERIOD 37
FIGURE 19 AEROBIC COUNT SEGMENT TO COMMAND LARGEST SHARE OF THE MARKET
IN 2018 46
FIGURE 20 RAW MATERIALS TESTING SEGMENT TO COMMAND LARGEST SHARE OF THE MARKET IN 2018 52
FIGURE 21 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE THE BIOBURDEN TESTING MARKET DURING THE FORECAST PERIOD 59
FIGURE 22 ASIA TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
(2018–2023) 66
FIGURE 23 NORTH AMERICA: MARKET SNAPSHOT 68
FIGURE 24 EUROPE: MARKET SNAPSHOT 78
FIGURE 25 KEY DEVELOPMENTS IN THE BIOBURDEN TESTING MARKET FROM 2015 TO 2018 98
FIGURE 26 MARKET EVOLUTION FRAMEWORK 99
FIGURE 27 BIOBURDEN TESTING MARKET RANKING, BY KEY PLAYER, 2017 99
FIGURE 28 CHARLES RIVER: COMPANY SNAPSHOT (2017) 103
FIGURE 29 MERCK KGAA: COMPANY SNAPSHOT (2017 105

FIGURE 30 SGS SA: COMPANY SNAPSHOT (2017) 108
FIGURE 31 BD: COMPANY SNAPSHOTS (2017) 113
FIGURE 32 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOTS (2017) 117
FIGURE 33 BIOMÉRIEUX SA: COMPANY SNAPSHOTS (2017) 119


★調査レポート[バイオバーデン試験の世界市場予測(~2023年)] ( Bioburden Testing Market by Product (Consumables, Instrument (PCR, Microscope)), Test (Anerobic, Mold/Fungi, Aerobic, Spore), Application (Raw Material, Medical Devices, Sterility Testing), End User (Pharma, Biotechnology, CMO) - Global Forecast to 2023 / BT-3394) 販売に関する免責事項
[バイオバーデン試験の世界市場予測(~2023年)] ( Bioburden Testing Market by Product (Consumables, Instrument (PCR, Microscope)), Test (Anerobic, Mold/Fungi, Aerobic, Spore), Application (Raw Material, Medical Devices, Sterility Testing), End User (Pharma, Biotechnology, CMO) - Global Forecast to 2023 / BT-3394) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆